Conexeu Sciences Inc. (NASDAQ:CNXU) Short Interest Up 357.1% in July

Conexeu Sciences Inc. (NASDAQ:CNXU) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 170,673 shares, a growth of 357.1% from the June 30th total of 37,335 shares. Based on an average trading volume of 156,558 shares, the short-interest ratio is presently 1.1 days. Approximately 0.6% of the shares of the company are sold short.

Insiders Place Their Bets

In other news, Director Lynn Sebastian Purcell bought 202,500 shares of the company’s stock in a transaction on Thursday, June 18th. The shares were acquired at an average cost of $0.80 per share, with a total value of $162,000.00. Following the completion of the transaction, the director owned 2,734,240 shares of the company’s stock, valued at approximately $2,187,392. This trade represents a 8.00% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Conexeu Sciences to a “hold” rating in a research note on Saturday, May 30th. Zacks Research upgraded shares of Conexeu Sciences to a “hold” rating in a research report on Monday, June 29th. Finally, HC Wainwright assumed coverage on shares of Conexeu Sciences in a report on Monday, June 22nd. They set a “buy” rating and a $20.00 target price for the company. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $20.00.

Conexeu Sciences Price Performance

Conexeu Sciences stock traded down $1.07 during trading on Monday, reaching $7.50. The company had a trading volume of 71,976 shares, compared to its average volume of 101,326. The stock has a market capitalization of $200.71 million and a price-to-earnings ratio of -68.32. The business’s 50-day moving average is $11.71. Conexeu Sciences has a 52 week low of $7.30 and a 52 week high of $18.79.

Conexeu Sciences (NASDAQ:CNXU) last released its quarterly earnings results on Monday, June 15th. The company reported ($0.11) earnings per share (EPS) for the quarter.

Conexeu Sciences Company Profile

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.